Hyperghrelinemia in the patients presenting with Prader-Willi syndrome

May 2014
Problemy Endokrinologii;2014, Vol. 60 Issue 3, p30
Academic Journal
The present study was designed to measure pre- and postprandial ghrelin secretion in the children presenting with Prader-Willi syndrome (PWS). The clinical, hormonal, and metabolic characteristics of 17 prepubertal children with the genetically verified diagnosis of PWS, 15 patients with exogenous-constitutional obesity, and 10 healthy children are presented. The children suffering PWS were found to exhibit pre- and postprandial hyperghrelinemia.


Related Articles

  • Birth prevalence of Prader-Willi syndrome in Australia. Smith, A.; Egan, J.; Ridley, G.; Haan, E.; Montgomery, P.; Williams, K.; Elliott, E. // Archives of Disease in Childhood;Mar2003, Vol. 88 Issue 3, p263 

    Background: Until recently, midazolam sedation was routinely used in our institution for bone marrow aspirates and lumbar punctures in children with cancer. It has been perceived by many doctors and nurses as being well tolerated by children and their families. Aim: To compare the efficacy of...

  • Correlation between Hyperghrelinemia and Carotid Artery Intima-Media Thickness in Children with Prader-Willi Syndrome. Su Jin Kim; Kyung Hoon Paik; Dong-Ik Kim; Yon Ho Choe; Seon Woo Kim; Dong-Kyu Jin // Yonsei Medical Journal;5/1/2010, Vol. 51 Issue 3, p339 

    Purpose: Prader-Willi syndrome (PWS) is a genetic disorder characterized by childhood-onset obesity and endocrine dysfunction that leads to cardiovascular disability. The objective of the study is to assess the relationship between carotid intima-media thickness (IMT) and atherosclerotic risk...

  • From the Editor. Albertini, David F. // Journal of Assisted Reproduction & Genetics;Aug2009, Vol. 26 Issue 8, p425 

    The author reflects on the importance of recent advances in genetic diagnoses for a better characterization of debilitating skeletal disorders and imprinting disorders. He informs that adverse gestational conditions is brought by children with Prader-Willi Syndrome. The author shares that...

  • Lucina.  // Archives of Disease in Childhood;Jul2002, Vol. 87 Issue 1, p86 

    Presents news updates on childhood diseases, compiled as of July 2002. Prevalence of phobias in children; Risk factors for the onset of wheezing; Incidence of severe psychiatric treatment in adults with Prader Willi syndrome.

  • Atoms. Bauchner, Howard // Archives of Disease in Childhood;Dec2008, Vol. 93 Issue 12, pi 

    The article offers news briefs related to childhood diseases. Growth hormone for children with Prader-Wili syndrome might have long-term adverse effects, including the worsening of obstructive sleep apnoea. There is a declined number of incidence of infantile hyperthropic pyloric stenosis...

  • Assessment of Hyperphagia in Prader-Willi Syndrome. Dykens, Elisabeth M.; Maxwell, Melissa A.; Pantino, Elizabeth; Kossler, Rebecca; Roof, Elizabeth // Obesity (19307381);Jul2007, Vol. 15 Issue 7, p1816 

    The article discusses the results of a study that assesses hyperphagia in Prader-Willi syndrome (PWS). It says that complications of obesity resulting from hyperphagia is the main cause of death in PWS. It states that the Hyperphagia Questionnaire which has been administered to parents of...

  • Development of the eating behaviour in Prader-Willi Syndrome: advances in our understanding. McAllister, C. J.; Whittington, J. E.; Holland, A. J. // International Journal of Obesity;Feb2011, Vol. 35 Issue 2, p188 

    Prader-Willi Syndrome (PWS) is a genetically determined neurodevelopmental disorder associated with mild to moderate intellectual disability, growth and sex-hormone deficiencies and a propensity to overeat that leads to severe obesity. The PWS phenotype changes from an early disinterest in food...

  • A general overview of Prader-Willi syndrome. Pogson, Delia // Independent Nurse;5/21/2012, p1 

    The article focuses on the Prader-Willi syndrome (PWS), a complex genomic imprinted condition, arising due to the absence of genes from the chromosome 15q11.2-13 region attributed to various causative factors. Further elucidated are the genotype and the five stages of PWS ranging from the...

  • Somatropin.  // Reactions Weekly;3/27/2004, Issue 994, p13 

    Discusses research being done on a boy who developed bronchopneumonia and experienced sudden death after starting treatment with somatropin for Prader-Willi syndrome. Reference to a study by G. van Vliet et al, published in the January 2004 issue of the "Journal of Pediatrics"; Reason for the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics